Categories: News

Cellebrite to Report First-Quarter 2026 Financial Results on May 14, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 21, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its first-quarter 2026 financial results before the U.S. markets open on Thursday, May 14, 2026.

- Advertisement -

Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the first quarter of 2026 and discuss its 2026 outlook. Relevant details include:

- Advertisement -

Date:

Thursday, May 14, 2026

Time:

8:30 a.m. ET

Call-In Number:

203-518-9814 / 800-274-8461

Conference ID: 

CLBTQ126

Event URL:

https://investors.cellebrite.com/events/event-details/cellebrite-q1-2026-financial-results-conference-call-webcast

Live Webcast URL:

https://edge.media-server.com/mmc/p/7b5rowvx

In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.

- Advertisement -

About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.

- Advertisement -

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

- Advertisement -

Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

- Advertisement -

Logo – https://mma.prnewswire.com/media/2855183/5926073/Cellebrite_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-to-report-first-quarter-2026-financial-results-on-may-14-2026-302747799.html

- Advertisement -

Recent Posts

TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com Releases Analysis: Which GLP-1 is Best?…

6 hours ago

From Living Rooms to Garages: GARVEE Expands Affordable Cooling Solutions for Summer 2026

ONTARIO, Calif., June 21, 2026 (GLOBE NEWSWIRE) -- GARVEE launches the 2026 Summer AC Campaign…

6 hours ago

Crypto News: AlphaPepe Expands Listings With BiFinance CEX Deal as Bitcoin Price Prediction Eyes $250,000

MONACO, June 20, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

6 hours ago

Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026

SHERMAN OAKS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Dr. Austin Harris, MD, founder of…

18 hours ago

Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

June 19, 2026 16:02 ET  | Source: Eupraxia Pharmaceuticals Inc. VANCOUVER, British Columbia, June 19,…

18 hours ago